VTE recurrence in patients with inherited deficiencies of natural anticoagulants

Thromb Haemost. 2009 Jan;101(1):5-6.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use
  • Antithrombin III Deficiency / complications
  • Antithrombin III Deficiency / drug therapy
  • Antithrombin III Deficiency / genetics*
  • Disease-Free Survival
  • Genetic Predisposition to Disease
  • Hemorrhage / chemically induced
  • Humans
  • Incidence
  • Pedigree
  • Protein C Deficiency / complications
  • Protein C Deficiency / drug therapy
  • Protein C Deficiency / genetics*
  • Protein S Deficiency / complications
  • Protein S Deficiency / drug therapy
  • Protein S Deficiency / genetics*
  • Recurrence
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Venous Thromboembolism / genetics*
  • Venous Thromboembolism / prevention & control
  • Vitamin K / antagonists & inhibitors

Substances

  • Anticoagulants
  • Vitamin K